Veterinary dermatology · 2022
A case of cutaneous bullous mastocytosis in a Yorkshire terrier puppy.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Petak Ana, Šoštarić-Zuckermann Ivan-Conrado, Gudan Kurilj Andrea, Lemo Nikša
Аннотация
BACKGROUND: Cutaneous bullous mastocytosis (CBM) is a rare disease characterised by erythroderma, bullae formation on trunk, scalp and extremities which evolve to erosions.
OBJECTIVE: To describe a rare variant of cutaneous mastocytosis and treatment options.
ANIMAL: A 7-month-old Yorkshire terrier puppy with erythroderma and bullae formation.
METHODS: Clinical examination (including haematological, biochemical and radiographic), skin biopsy, histopathological and immunohistochemical evaluation.
CONCLUSION AND CLINICAL RELEVANCE: The case fulfills the criteria of CBM, representing a rare entity that is reported to be associated with spontaneous regression. However, in severe cases treatment with systemic corticosteroids, H1 and H2 antihistamines, and masitinib can be performed.
OBJECTIVE: To describe a rare variant of cutaneous mastocytosis and treatment options.
ANIMAL: A 7-month-old Yorkshire terrier puppy with erythroderma and bullae formation.
METHODS: Clinical examination (including haematological, biochemical and radiographic), skin biopsy, histopathological and immunohistochemical evaluation.
CONCLUSION AND CLINICAL RELEVANCE: The case fulfills the criteria of CBM, representing a rare entity that is reported to be associated with spontaneous regression. However, in severe cases treatment with systemic corticosteroids, H1 and H2 antihistamines, and masitinib can be performed.